22 Dec 2020 Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study Member news
27 Sep 2020 Jyseleca® (filgotinib) approved by European Commission for rheumatoid arthritis Member news
26 Jun 2020 US multicenter study shows Idylla™ allows rapid and accurate mutation testing results across different laboratory settings Member news
11 Jun 2020 Mithra signs LSA for commercialization of Tibelia® in Liechtenstein and Switzerland Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us